Galera Therapeutics
IPO
Transforming the science and treatment of cancer.
- Employees
- 1–10
- Business Model
- B2B
- Website
- galeratx.com
- Total Funding
- $203.0M
- Last Round
- $150.0M Series CSep 2018
About
Galera Therapeutics is a clinical-stage biopharmaceutical company pioneering novel small molecules that target critical vulnerabilities in cancer cells, immune cells, and the tumor microenvironment. Based in Malvern, Pennsylvania, Galera focuses on improving the anti-cancer efficacy of current therapies, particularly for patients with breast cancer.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account